FDA 483 - HHS Systems Inc. - April 25, 2019

An FDA inspection of MHS Systems Inc. in Suffern, NY, a medical device manufacturer, revealed significant deficiencies across its quality system. The firm failed to maintain product acceptance status, establish numerous critical quality system procedures, and properly define its organizational structure for design controls. These observations indicate a fundamental lack of established controls and procedures essential for ensuring device quality and regulatory compliance.